Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

Amplitude Therapeutics Partners with Eli Lilly | PharmExec - Pharmaceutical Executive

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Aurinia Pharmaceuticals (AUPH) After The Teva Settlement Is The Stock A Bargain - simplywall.st

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

BioCryst Pharmaceuticals (NASDAQ:BCRX) Passes Minervini Trend Template and High-Growth Momentum Screen - ChartMill

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Citius Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Telix Pharmaceuticals (ASX:TLX) The Business Is Profitable, So Why Raise More Equity? - Stocks Down Under

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Aurinia settles with Teva, helping stave off potential Lupkynis generic until late 2036 - Fierce Pharma

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

$100 Invested In Ligand Pharmaceuticals 10 Years Ago Would Be Worth This Much Today - Benzinga

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Why Amylyx Pharmaceuticals Blasted Nearly 79% Higher This Week - The Motley Fool

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead - Yahoo Finance

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Moroccan billionaire Anas Sefrioui expands from property into pharmaceuticals with Servier deal - Business Insider Africa

news.google.com · 22 Aug 2026

Google News – Biopharma External News

Replimune melanoma drug wins support of FDA panel - BioPharma Dive

news.google.com · 22 Aug 2026

Google News – Biopharma External News

Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb - Pharmaceutical Executive

news.google.com · 22 Aug 2026

Google News – Biopharma External News

iX Biopharma reports lower losses of $8 mil for FY2026; near-term priority on EUA application - The Edge Singapore

news.google.com · 22 Aug 2026

Google News – Biopharma External News

Quantum Biopharma Provides Corporate Update - The Spec

news.google.com · 22 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device

Trump nominates policy aide Overton to lead FDA

FDA seeks feedback on generative AI regulations

GE HealthCare names new CFO

Amplitude Therapeutics Partners with Eli Lilly | PharmExec - Pharmaceutical Executive

Aurinia Pharmaceuticals (AUPH) After The Teva Settlement Is The Stock A Bargain - simplywall.st

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

BioCryst Pharmaceuticals (NASDAQ:BCRX) Passes Minervini Trend Template and High-Growth Momentum Screen - ChartMill

Citius Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Telix Pharmaceuticals (ASX:TLX) The Business Is Profitable, So Why Raise More Equity? - Stocks Down Under

Aurinia settles with Teva, helping stave off potential Lupkynis generic until late 2036 - Fierce Pharma

$100 Invested In Ligand Pharmaceuticals 10 Years Ago Would Be Worth This Much Today - Benzinga

Why Amylyx Pharmaceuticals Blasted Nearly 79% Higher This Week - The Motley Fool

Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead - Yahoo Finance

Moroccan billionaire Anas Sefrioui expands from property into pharmaceuticals with Servier deal - Business Insider Africa

Replimune melanoma drug wins support of FDA panel - BioPharma Dive

Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb - Pharmaceutical Executive

iX Biopharma reports lower losses of $8 mil for FY2026; near-term priority on EUA application - The Edge Singapore

Quantum Biopharma Provides Corporate Update - The Spec